Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 406 of 5804
-
Nearly 10,000 heart attack patients to test ancient pill for better recovery
Disease control Not yet recruitingThis study aims to evaluate the value of Shexiang Baoxin Pill (MUSKARDIA) in patients with acute myocardial infarction (AMI) through a prospective, multicenter, pragmatic randomized controlled real-world study. It seeks to validate its efficacy in reducing cardiovascular event ri…
Phase: PHASE4 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
New AI tool could spot dangerous liver cancer invasion without a biopsy
Diagnosis Recruiting nowHepatocellular carcinoma (HCC) is a common malignancy in China with a high mortality rate. Its early recurrence and long-term prognosis are closely associated with tumor aggressiveness. Microvascular invasion (MVI), defined as the presence of tumor cells within small branches of …
Sponsor: Chinese Academy of Sciences • Aim: Diagnosis
Last updated Jun 26, 2026 15:47 UTC
-
New trial aims to find safer chemo for stem cell transplants in leukemia patients
Disease control Not yet recruitingThe aim of this study is to compare the effectiveness and tolerability of two conditioning chemotherapies prior to allogeneic stem cell transplantation. The following will also be investigated: * Survival * Remission and Relapse rate * Engraftment or graft failure * Graft versu…
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated Jun 26, 2026 12:47 UTC
-
New gel could ease blistering for skin disorder patients
Disease control Recruiting nowThis Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (4 years of age and older) diagnosed with generalized intermediate to severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) …
Phase: PHASE2 • Sponsor: BioMendics, LLC • Aim: Disease control
Last updated Jun 26, 2026 15:57 UTC
-
New study aims to prevent brain damage in preterm infants after bleeding
Disease control Not yet recruiting1. Establish a reference curve for the lateral ventricular diameter of premature infants and determine the intervention threshold for hydrocephalus after hemorrhage in premature infants based on the reference curve, providing a scientific basis for optimizing clinical interventio…
Phase: NA • Sponsor: Second Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 13:25 UTC
-
Could a common steroid boost survival after major stroke?
Disease control Recruiting nowThe efficacy and safety of early adjunctive methylprednisolone therapy in acute ischemic stroke patients with large infarct cores (ASPECTS score \< 6) and post-stroke lymphocytopenia remain unclear. These immunocompromised patients face higher mortality rates and poorer clinical …
Phase: PHASE3 • Sponsor: YiLin • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug cocktail aims to shrink Hard-to-Treat breast tumors
Disease control Not yet recruitingThis is an open-label, single-arm, multicenter phase II study to evaluate the safety and efficacy of sac-TMT plus Tagitanlimab in patients with PD-L1-positive locally advanced or metastatic TNBC.
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
Could a fibrosis drug help women with adenomyosis get pregnant?
Disease control Not yet recruitingThis study aims to evaluate the effectiveness and safety of nintedanib, an antifibrotic drug, in improving live birth rates for infertile women with adenomyosis who have frozen embryos. Based on promising animal data showing reduced uterine fibrosis, participants will be randomiz…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 26, 2026 14:46 UTC
-
New hope for rare lymphoma: drug combo targets tough cancer
Disease control Not yet recruitingEvaluation of the Safety and Efficacy of Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Immune reset: CAR-T therapy takes on lupus, myositis, and ITP
Disease control Recruiting nowThis is a single arm, open-label, dose escalation and expansion study to evaluate the safety, tolerability and preliminary efficacy of autologous chimeric antigen receptor T (CAR-T) cells targeting CD19/CD22/BCMA(BZE2204) in patients with relapsed or refractory active autoimmune …
Phase: EARLY_PHASE1 • Sponsor: Shanghai Cell Therapy Group Co.,Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:04 UTC
-
Immunotherapy before surgery could boost cervical cancer outcomes
Disease control Not yet recruitingFor locally advanced cervical cancer, there are two main treatment options: One is radical chemoradiotherapy (a combination of radiotherapy and chemotherapy aimed at curing the disease). The other is having neoadjuvant treatment first (treatment given before the main surgery to…
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New combo aims to keep leukemia at bay after remission
Disease control Recruiting nowthis study will explore the efficacy of maintenance SC cytarabine + venetoclax therapy as regard disease free survival (DFS) in AML fit patients who achieved CR after highly aggressive chemotherapy as bridge for BMT or if BMT will be delayed or canceled due to any other reason.
Phase: NA • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a nasal spray help kids with autism? new trial begins
Disease control Recruiting nowThis clinical study aims to evaluate whether a nasal spray containing exosomes derived from human umbilical cord mesenchymal stem cells (hUC-MSC-EXOs) can safely and effectively improve core symptoms in children aged 3-7 years with autism spectrum disorder (ASD). It is a 24-week,…
Phase: PHASE1, PHASE2 • Sponsor: Dongfang People's Hospital • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Spinal stimulator trial aims to help paralyzed patients walk again
Disease control Recruiting nowSpinal cord stimulation (SCS) has been shown in previous studies to be capable of restoring motor and autonomic function in patients with chronic complete spinal cord injury (SCI). Clinical studies have demonstrated that SCS enables activation of previously paralyzed muscles, lea…
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
RSV showdown: vaccine for moms vs. antibody for newborns – which works better?
Prevention OngoingBronchiolitis is a lower respiratory tract infection, extremely common in pediatrics, and potentially serious. Bronchiolitis affects nearly 30% of infants under 2 years old each year, representing approximately 480,000 cases annually worldwide. Each year, 2 to 3% of infants under…
Sponsor: Jean-Michel HASCOET • Aim: Prevention
Last updated Jun 27, 2026 08:00 UTC
-
New leukemia combo aims for higher remission rates
Disease control Recruiting nowThis study is a multicenter, randomized, prospective Phase II clinical trial designed to compare the effectiveness of two treatment approaches for patients with acute monocytic leukemia.
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
PrEP goes local: Community-Based HIV prevention trial launches in rio
Prevention Recruiting nowThis study aims to improve access to HIV prevention using pre-exposure prophylaxis (PrEP) among underserved populations in Rio de Janeiro, including gay and bisexual men, transgender women, and sex workers. Despite the proven effectiveness of PrEP, many people at higher risk of H…
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
AI reads ultrasound videos to spot dangerous placenta condition
Diagnosis Recruiting nowThis study develops an end-to-end Vision Transformer (ViT)-based artificial intelligence system for ultrasound-based diagnosis of placenta accreta spectrum (PAS), aiming to improve the accuracy and efficiency of prenatal screening using standardized ultrasound video inputs.
Sponsor: FANG HE • Aim: Diagnosis
Last updated Jun 27, 2026 13:05 UTC
-
Robotic scalpel vs Surgeon's hand: which is safer for pancreatic cancer surgery?
Disease control Recruiting nowPancreatic surgery, specifically pancreatoduodenectomy (PD), is a complex procedure often required for patients with pancreatic or other periampullary cancers. In recent years, minimally invasive techniques have become more popular, especially robotic-assisted surgery. However, t…
Phase: NA • Sponsor: Hospital del Mar • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a daily injection tame two rare inflammatory diseases?
Disease control TerminatedThe purpose of this study is to evaluate the efficacy and safety of anakinra in Chinese patients with Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still's Disease (AOSD).The study consists of up to four weeks screening, to see if a patient is suitable to the stud…
Phase: PHASE4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC